Gentis develops biomaterials-based products for the treatment of early-stage degeneration of the spine.
11 years ago
Easton Capital, Pappas Ventures, Ivy Capital, Matignon Investissement & Gestion
Use Gentis's historical employee count to better understand their growth and spending over time.
Unlock with a Free Trial
Use Gentis's historical Linkedin followers to better understand their social media traction over time.
Use Gentis's mobile downloads and app ranks to evaluate the performance of their mobile apps.